However, intravenous administration of human albumin at a dose of 10 g every 2 weeks in patients with mild or moderate AD did not significantly reduce the cognitive decline as measured by the MMSE and ADAS-cog at 28 weeks. The gene discussed is ALB; the disease is Mental deterioration.